Evommune, Inc. (EVMN)
25.61
-0.39
(-1.50%)
USD |
NYSE |
Mar 02, 16:00
26.07
+0.46
(+1.80%)
Pre-Market: 20:00
Evommune Shareholders Equity (Quarterly) : -183.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Moderna, Inc. | 8.65B |
| BillionToOne, Inc. | 179.90M |
| Nektar Therapeutics | 85.09M |
| CorMedix, Inc. | 374.13M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.54M |
| Total Liabilities (Quarterly) | 267.68M |
| Debt to Equity Ratio | -1.408 |
| Current Ratio | 7.761 |